Bragar Eagel & Squire, P.C. is Investigating Certain Officers and Directors of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) and Encourages Zimmer Investors to Contact the Firm

NEW YORK, June 06, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of Zimmer Biomet Holdings, Inc. (NYSE: ZBH).

Click here to participate in the action.

On March 21, 2019, an amended complaint was filed alleging that between June 6, 2016 and November 7, 2016, defendants issued a series of material misstatements and omissions to investors regarding, among other things, (1) Zimmer’s discovery of wide-ranging “systemic issues” with the quality system at the primary Legacy Biomet manufacturing facility in Warsaw; (2) Zimmer’s failure to take prompt and necessary actions to remediate these issues fully; and (3) Zimmer’s inability to simultaneously satisfy the demand for its products while remediating these issues.

If you are a long term stockholder of Zimmer, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into Zimmer, please go to For additional information about Bragar Eagel & Squire, P.C. please go to Attorney advertising. Prior results do not guarantee similar outcomes. 


Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648